SPONSORED CONTENT
The Health Resources and Services Administration (HRSA) conducts randomized audits to assess compliance with the 340B drug pricing program, a federal initiative aimed at providing discounted medications to eligible entities. With more than 13,100 parent entities participating in 340B, this increased participation comes with the responsibility of increased oversight and the likelihood of audits. It’s no longer a question of whether you’ll be audited; it’s a matter of when.
Covered entities with leading practice program auditing processes benefit from continuous insight into program performance, which supports ongoing improvement efforts and perpetual compliance, ultimately allowing these organizations to stretch their resources as far as possible. Apexus provides tools and resources that give guidance on how to optimize a 340B program, minimize noncompliance issues, and effectively prepare for a HRSA audit through the Apexus Advanced 340B Operations Certificate Program.
Managing Expectations: What to Expect During a HRSA Audit
Randomized HRSA